Friday, 21 Jul 2017

You are here

The RheumNow Week in Review – 9 June 2017

Dr. Jack Cush reviews the news and reports of interest from RheumNow in the last week:

  1. Abbvie Scholarship program accepting applications to award 15 grants ($15k/yr) to Students with Rheumatic disorders https://t.co/lgDLQRznJN
  2. Using Claims data, Allopurinol associated with lower risk of incident renal disease (HR 0.61) compared to febuxostat https://t.co/iGUKB4MxK0
  3. SLE myositis more likely to have rash, alopecia, pericarditis, vasculitis, Sm, RNP, dsDNA, low Plts & WBC, low C3.C4 https://t.co/UwWVr1XuhY
  4. Autoimmune diseases w/ MYOCARDITIS include sarcoidosis, Behçets, Churg-Strauss, inflammatory myositis, SLE https://t.co/zb3LdzUL9G
  5. QUEST-RA study shows the average RA pt has 2+ comorbidities (HTN, OP,OA); fatigue assoc w/ comorbidity & dz activity https://t.co/BPTsGW82ho
  6. Retro review of open label Tofacitinib 5 mg bid in 13 pts w/ alopecia areata showing ~50% regrowth after 4-5 mos https://t.co/Umw6vCOp3j
  7. Case reports showing tofacitinib, ruloxocitinb efficacy in difficult dermatomyositis, leads makers of JAK inhibitors to consider RCTs in DM
  8. Metormins effx mediated by change in gut microbiome; transfer of metformin-altered microbiota improves Glu tolerance https://t.co/1HvCnS19kW
  9. FDA Requests Removal of OPANA-ER from the Market 
  10. Debate over Alcohol and Methotrexate Precautions 
  11. Biosimilar Reports – May 2017
  12. Higher Fracture Risks with Prolonged Bisphosphonate Use in Older Women

 

 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – 21 July 2017

Dr. Jack Cush reviews the news from the past week on RheumNow.com: 

The RheumNow Week in Review – 14 July 2017

Dr. Jack Cush reviews highlights from the past week on RheumNow.com:

Pharma Pays $8.2 Billion to Physicians in 2016

Data made public by the Centers for Medicare & Medicaid Services shows that drug and device makers made nearly $8.2 billion in payments to U.S. physicians and teaching hospitals in the last year. Since 2013, CMS has been tracking physician payments as part of the Affordable Care Act.

The RheumNow Week in Review – 30 June 2017

Dr. Jack Cush reviews highlights from the past week on RheumNow.com:

ACR Says Senate Healthcare Bill Falls Short of Protecting Americans with Rheumatic Disease

Dr. Sharad Lakhanpal, President of the American College of Rheumatology has responded to the Senate's proposed changes to healthcare coverage in the USA.